In a breakthrough which may pave way for an effective treatment of inoperable cancers, scientists at the Bhabha Atomic Research Centre have developed radio pharmaceuticals, which they claim can be used for curing skin and liver tumours besides alleviating rheumatic arthritis.
"A research carried out in BARC in collaboration with few hospitals in the country has shown Lutetium-177 (Lu-177), Yittrium-90 (Y-90) and Phosphorus-32 (P-32) as very effective therapeutic radionuclides (radio pharmaceuticals) that can be used in the treatment of cancers of liver, skin and in non-cancerous maladies such as rheumatic arthritis and haemophilia," Meera Venkatesh, Head, Radio pharmaceuticals Division told PTI.